Parkside Financial Bank & Trust Charles River Laboratories International, Inc. Transaction History
Parkside Financial Bank & Trust
- $772 Million
- Q1 2025
A detailed history of Parkside Financial Bank & Trust transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 1,008 shares of CRL stock, worth $151,210. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,008
Previous 915
10.16%
Holding current value
$151,210
Previous $168,000
10.12%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$916 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$763 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$643 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$359 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$293 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.63B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...